Windsor Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $610K | Buy |
|
|||||
|
2025
Q2 | $488K | Buy |
|
|||||
|
2025
Q1 | $549K | Buy |
|
|||||
|
2024
Q4 | $457K | Buy |
|
|||||
|
2024
Q3 | $506K | Buy |
|
|||||
|
2024
Q2 | $417K | Buy |
|
|||||
|
2024
Q1 | $442K | Buy |
|
|||||
|
2023
Q4 | $358K | Buy |
|
|||||
|
2023
Q3 | $343K | Buy |
|
|||||
|
2023
Q2 | $309K | Buy |
|
|||||
|
2023
Q1 | $364K | Buy |
|
|||||
|
2022
Q4 | $368K | Buy |
|
|||||
|
2022
Q3 | $227K | Buy |
|
|||||
|
2022
Q2 | $258K | Buy |
|
|||||
|
2022
Q1 | $272K | Buy |
|
|||||
|
2021
Q4 | $226K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $238K | Buy |
|
|||||
|
2021
Q1 | $202K | Sell |
|
|||||
|
2020
Q4 | $253K | Buy |
|
|||||
|
2020
Q3 | $206K | Buy |
|
|||||
|
2020
Q2 | $230K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $210K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $227K | Sell |
|
|||||
|
2018
Q3 | $1.02M | Sell |
|
|||||
|
2018
Q2 | $1.03M | Buy |
|
|||||
|
2018
Q1 | $999K | Sell |
|
|||||
|
2017
Q4 | $1.17M | Sell |
|
|||||
|
2017
Q3 | $979K | Hold |
|
|||||
|
2017
Q2 | $979K | Buy |
|
|||||
|
2017
Q1 | $855K | Buy |
|
|||||
|
2016
Q4 | $269K | Buy |
|
|||||
|
2016
Q3 | $271K | Sell |
|
|||||
|
2016
Q2 | $801K | Buy |
|
|||||
|
2016
Q1 | $718K | Buy |
|
|||||
|
2015
Q4 | $549K | Buy |
|
|||||
|
2015
Q3 | $470K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $104K | Buy |
|
|||||
|
2013
Q3 | $88K | Sell |
|
|||||
|
2013
Q2 | $90K | Buy |
|